Article
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers
- Rallybio (NASDAQ:RLYB) shares moved upwards by 25.6% to $9.47 during Monday's regular session. The market value of their outstanding shares is at $39.8 million.
- Astrana Health (NASDAQ:ASTH) shares moved upwards by 24.44% to $25.3. The company's market cap stands at $1.0 billion. The company's, Q4 earnings came out today.
- Hyperliquid Strategies (NASDAQ:PURR) stock increased by 21.32% to $4.95. The company's market cap stands at $505.7 million.
- Rafael Holdings (NYSE:RFL) stock moved upwards by 20.86% to $1.53. The market value of their outstanding shares is at $65.7 million.
- Compugen (NASDAQ:CGEN) shares rose 20.44% to $2.18. The market value of their outstanding shares is at $169.2 million. As per the news, the Q4 earnings report came out today.
- Bristol-Myers Squibb Company Celegne Contingent Value Rights (NYSE:CELGR) shares increased by 19.44% to $0.12.
Losers
- Aardvark Therapeutics (NASDAQ:AARD) shares decreased by 55.4% to $5.58 during Monday's regular session. The market value of their outstanding shares is at $271.9 million.
- Pulmatrix (NASDAQ:PULM) shares decreased by 35.79% to $1.92. The market value of their outstanding shares is at $10.9 million. The company's, Q4 earnings came out 2 days ago.
- uniQure (NASDAQ:QURE) shares decreased by 35.13% to $10.14. The market value of their outstanding shares is at $973.6 million. The company's, Q4 earnings came out today.
- Cardio Diagnostics Hldgs (NASDAQ:CDIO) shares declined by 29.32% to $4.63. The market value of their outstanding shares is at $11.9 million.
- BioAtla (NASDAQ:BCAB) shares decreased by 24.01% to $0.19. The market value of their outstanding shares is at $18.3 million.
- ClearPoint Neuro (NASDAQ:CLPT) shares fell 21.64% to $9.85. The market value of their outstanding shares is at $373.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Comments
- No comments yet. Be the first to comment!